🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Status
Unknown
Location
Banner Health - MD Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03634332
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This study is being done to learn more about a new drug called Bapotulimab ...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2018-09-12
Trial ID
NCT03666273
Treatments Being Tested
The primary objective is to determine if mutation load underlies sensitivit...
Status
Terminated
Location
Columbia University
Start Date
2016-05-31
Trial ID
NCT02710396
Treatments Being Tested
This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-07-06
Trial ID
NCT04369937
Treatments Being Tested
The purpose of this study is to test how safe and effective the research st...
Status
Unknown
Location
Concord Hospital
Start Date
2018-11-29
Trial ID
NCT03331731
Treatments Being Tested
This is a phase I/Ib study of adoptively transferred T-cell receptor gene-e...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2023-04-03
Trial ID
NCT05349890
Treatments Being Tested